Relativity Acquisition Corp. and Instinct Brothers Announce Extraordinary General Meeting of Relativity Shareholders to Approve Business Combination

In this episode of Global Economic Press, Alex Brady discusses a significant development in the mergers and acquisitions landscape involving Relativity Acquisition Corporation and Instinct Brothers Company, Limited. Relativity Acquisition Corporation, a special-purpose acquisition company, and Instinct Brothers, a leader in the stem cell and regenerative medicine sector, have announced an extraordinary general meeting of Relativity shareholders to approve a major business combination. This meeting is scheduled to be held virtually on Wednesday, March 25, 2026, at 9:30 a.m. Eastern Time. The announcement follows the United States Securities and Exchange Commission's declaration of the effectiveness of the Registration Statement on Form F-4 filed in connection with the Business Combination. Shareholders of record as of February 25, 2026, are entitled to vote on the Business Combination and related matters. Instinct Brothers, a Japanese company specializing in stem cell skincare and wellness products, aims to drive innovation in regenerative medicine under the leadership of Tomoki Nagano. The Business Combination, if approved, will result in the post-combination company listing its securities on the Nasdaq Stock Market under the proposed ticker symbols "BIOT" and "BIOTW." Relativity Acquisition Corporation focuses on identifying market-leading companies with disruptive potential in the health, wellness, and technology sectors. For more information about Relativity Acquisition Corporation, visit their website at Relativity Acquisition Corp.